Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Ovarian Neoplasms and EGFR[original query] |
|---|
| Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Mar 26 (7): 1119-27. Rudin Charles M, Liu Wanqing, Desai Apurva, Karrison Theodore, Jiang Xuemin, Janisch Linda, Das Soma, Ramirez Jacqueline, Poonkuzhali Balasubramanian, Schuetz Erin, Fackenthal Donna Lee, Chen Peixian, Armstrong Deborah K, Brahmer Julie R, Fleming Gini F, Vokes Everett E, Carducci Michael A, Ratain Mark |
| KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay. BMC cancer 2009 9 111. Auner Veronika, Kriegshäuser Gernot, Tong Dan, Horvat Reinhard, Reinthaller Alexander, Mustea Alexander, Zeillinger Robe |
| Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Experimental biology and medicine (Maywood, N.J.) 2009 Mar 234 (3): 241-5. Araújo Ana Paula, Ribeiro Ricardo, Pereira Deolinda, Pinto Daniela, Sousa Berta, Catarino Raquel, Medeiros R |
| Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer. Cancer biology & therapy 2011 Jan 11 (1): 50-7. Tanaka Yoshimichi, Terai Yoshito, Tanabe Akiko, Sasaki Hiroshi, Sekijima Tatsuharu, Fujiwara Satoe, Yamashita Yoshiki, Kanemura Masanori, Ueda Masatsugu, Sugita Michio, Franklin Wilbur A, Ohmichi Masahi |
| A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
| Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients. Current oncology (Toronto, Ont.) 2016 Oct 23 (5): 298-303. Jung J, Kang E, Gwak J M, Seo A N, Park S Y, Lee A S, Baek H, Chae S, Kim E K, Kim S |
| BRCA1 Mutation Status and Follicular Fluid Exposure Alters NF?B Signaling and ISGylation in Human Fallopian Tube Epithelial Cells. Neoplasia (New York, N.Y.) 2018 6 20 (7): 697-709. Hollingsworth Julia, Lau Angela, Tone Alicia, Kollara Alexandra, Allen Lisa, Colgan Terence J, Dube Valerie, Rosen Barry, Murphy K Joan, Greenblatt Ellen M, Feigenberg Tomer, Virtanen Carl, Brown Theodore |
| Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing. Scientific reports 2019 Jul 9 (1): 10426. Iwahashi Naoyuki, Sakai Kazuko, Noguchi Tomoko, Yahata Tamaki, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
| Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer. Neoplasia (New York, N.Y.) 2019 May 21 (6): 582-590. Van Nieuwenhuysen Els, Busschaert Pieter, Laenen Annouschka, Moerman Philippe, Han Sileny N, Neven Patrick, Lambrechts Diether, Vergote Igna |
| KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2019 May . Hewitt Lindsay C, Saito Yuichi, Wang Tan, Matsuda Yoko, Oosting Jan, Silva Arnaldo N S, Slaney Hayley L, Melotte Veerle, Hutchins Gordon, Tan Patrick, Yoshikawa Takaki, Arai Tomio, Grabsch Heike |
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
Cancer medicine 2019 Apr . Grant Delores J, Manichaikul Ani, Alberg Anthony J, Bandera Elisa V, Barnholtz-Sloan Jill, Bondy Melissa, Cote Michele L, Funkhouser Ellen, Moorman Patricia G, Peres Lauren C, Peters Edward S, Schwartz Ann G, Terry Paul D, Wang Xin-Qun, Keku Temitope O, Hoyo Cathrine, Berchuck Andrew, Sandler Dale P, Taylor Jack A, O'Brien Katie M, Velez Edwards Digna R, Edwards Todd L, Beeghly-Fadiel Alicia, Wentzensen Nicolas, Pearce Celeste Leigh, Wu Anna H, Whittemore Alice S, McGuire Valerie, Sieh Weiva, Rothstein Joseph H, Modugno Francesmary, Ness Roberta, Moysich Kirsten, Rossing Mary Anne, Doherty Jennifer A, Sellers Thomas A, Permuth-Way Jennifer B, Monteiro Alvaro N, Levine Douglas A, Setiawan Veronica Wendy, Haiman Christopher A, LeMarchand Loic, Wilkens Lynne R, Karlan Beth Y, Menon Usha, Ramus Susan, Gayther Simon, Gentry-Maharaj Aleksandra, Terry Kathryn L, Cramer Daniel W, Goode Ellen L, Larson Melissa C, Kaufmann Scott H, Cannioto Rikki, Odunsi Kunle, Etter John L, Huang Ruea-Yea, Bernardini Marcus Q, Tone Alicia A, May Taymaa, Goodman Marc T, Thompson Pamela J, Carney Michael E, Tworoger Shelley S, Poole Elizabeth M, Lambrechts Diether, Vergote Ignace, Vanderstichele Adriaan, Van Nieuwenhuysen Els, Anton-Culver Hoda, Ziogas Argyrios, Brenton James D, Bjorge Line, Salvensen Helga B, Kiemeney Lambertus A, Massuger Leon F A G, Pejovic Tanja, Bruegl Amanda, Moffitt Melissa, Cook Linda, Le Nhu D, Brooks-Wilson Angela, Kelemen Linda E, Pharoah Paul D P, Song Honglin, Campbell Ian, Eccles Diana, DeFazio Anna, Kennedy Catherine J, Schildkraut Joellen |
| Associations of CXCL1 gene 5'UTR variations with ovarian cancer. Journal of ovarian research 2020 Apr 13 (1): 43. Guo Man, Xu Chao, Chen Yan-Zhe, Sun Qi-Wen, Zhao Xin-Ying, Liu Xin, Yang Yi, Hu Yi-Yan, Li Fei-Feng, Liu Shu-L |
| Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals. Expert review of molecular diagnostics 2020 12 21 (1): 101-107. Cavic Milena, Krivokuca Ana, Boljevic Ivana, Spasic Jelena, Mihajlovic Milica, Pavlovic Marijana, Damjanovic Ana, Radosavljevic Davorin, Jankovic Radmi |
| Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact. Cancers 2020 Nov 12 (11): . Noguchi Tomoko, Iwahashi Naoyuki, Sakai Kazuko, Matsuda Kaho, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
| Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer: A retrospective study. Medicine 2021 9 100 (35): e27130. Gao Jie, Li Fang, Liu Zihao, Huang Mengli, Chen Huoming, Liao Guoqing, Meng Jichang, Wang Qing, Zhao Hui, Li Chenxi, Ji Jing, Cai Shangli, Du N |
| Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome. Computational and structural biotechnology journal 2021 9 19 4435-4446. Dong Qi, Liu Mingyue, Chen Bo, Zhao Zhangxiang, Chen Tingting, Wang Chengyu, Zhuang Shuping, Li Yawei, Wang Yuquan, Ai Liqiang, Liu Yaoyao, Liang Haihai, Qi Lishuang, Gu Yuny |
| Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients. Frontiers in oncology 2023 1 12 1064598. Shang Yanhong, Mo Jianming, Huo Ran, Li Xiaofang, Fang Guotao, Wei Zichun, Gu Guomin, Zhu Xiaodan, Zhang Chan, Liu Chunling, Yan Do |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: